"abbott-india"

Abbott India in its latest public notice revealed that it has issued a voluntary recall of a particular batch of Thyronorm tablets due to labeling error in Madhya Pradesh and Telangana.

The company had posted a net profit of Rs 186.69 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.